| Identification | |
| Name: | Medroxalol hydrochloride |
| Synonyms: | 5-[2-[[3-(1,3-benzodioxol-5-yl)-1-methylpropyl]amino]-1-hydroxyethyl]salicylamide monohydrochloride |
| CAS: | 70161-10-3 |
| EINECS: | 274-347-3 |
| Molecular Formula: | C20H24N2O5 . ClH |
| Molecular Weight: | 408.8759 |
| InChI: | InChI=1/C20H24N2O5.ClH/c1-12(2-3-13-4-7-18-19(8-13)27-11-26-18)22-10-17(24)14-5-6-16(23)15(9-14)20(21)25;/h4-9,12,17,22-24H,2-3,10-11H2,1H3,(H2,21,25);1H |
| Molecular Structure: | ![(C20H24N2O5.ClH) 5-[2-[[3-(1,3-benzodioxol-5-yl)-1-methylpropyl]amino]-1-hydroxyethyl]salicylamide monohydrochloride](https://img.guidechem.com/crawlimg/70161-10-3.png) |
| Properties | |
| Flash Point: | 319.1°C |
| Boiling Point: | 604.1°C at 760 mmHg |
| Density: | g/cm3 |
| Specification: |
Medroxalol hydrochloride , its cas register number is 70161-10-3. It also can be called 5-(1-Hydroxy-2-((1-methyl-3-(3,4-(methylenedioxy)phenyl)propyl)amino)ethyl)salicylamide monohydrochloride ; 5-(2-((3-(1,3-Benzodioxol-5-yl)-1-methylpropyl)amino)-1-hydroxyethyl)-2-hydroxybenzamide HCl ; Medroxalol HCl ; and Benzamide, 5-(2-((3-(1,3-benzodioxol-5-yl)-1-methylpropyl)amino)-1-hydroxyethyl)-2-hydroxy-, monohydrochloride . Its classification code are Antihypertensive; Drug / Therapeutic Agent and Tumor data. Medroxalol hydrochloride (CAS NO.70161-10-3) is an antihypertensive agent with beta 1 adrenergic cardiac blocking properties, and beta 2 and some alpha 1 vasodilating activity. |
| Flash Point: | 319.1°C |
| Safety Data | |
 |
|
